UNH

Unitedhealth Group
D

UNH

Arincen63/100B

Unitedhealth Group stock buybacks 1989–2026

Unitedhealth Group spent 3.39B USD buying back its shares in Q3 FY2026, the three months to 30 September 2026, down 28.6% on the same quarter a year before. Unitedhealth Group spent 5.55B USD buying back its shares in fiscal year 2025, down 38.4% on the year before.

Last updated 4 Nov 2026 · Next report 20 Jan 2027

Stock buybacks

Growth

Fiscal yearPeriod endingStock buybacksGrowthDividends paidFree cash flow
TTM30 Sept 2026——8.17B22.83B
FY202531 Dec 20255.55B-38.39%7.92B16.08B
FY202431 Dec 20249.00B+12.50%7.53B20.71B
FY202331 Dec 20238.00B+14.29%6.76B25.68B
FY202231 Dec 20227.00B+40.00%5.99B23.40B
FY202131 Dec 20215.00B+17.65%5.28B19.89B
FY202031 Dec 20204.25B-22.73%4.58B20.12B
FY201931 Dec 20195.50B+22.22%3.93B16.39B
FY201831 Dec 20184.50B+200.00%3.32B13.65B
FY201731 Dec 20171.50B+17.19%2.77B11.57B
FY201631 Dec 20161.28B+6.67%2.26B8.09B
FY201531 Dec 20151.20B-70.06%1.79B8.18B
FY201431 Dec 20144.01B+26.44%1.36B6.60B
FY201331 Dec 20133.17B+2.79%1.06B5.83B
FY201231 Dec 20123.08B+3.01%820.00M6.09B
FY201131 Dec 20112.99B+18.95%651.00M5.95B
FY201031 Dec 20102.52B+39.76%449.00M5.40B
FY200931 Dec 20091.80B-32.90%36.00M4.89B
FY200831 Dec 20082.68B-59.33%37.00M3.45B
FY200731 Dec 20076.60B+181.41%40.00M5.01B
FY200631 Dec 20062.35B-8.29%41.00M5.80B
FY200531 Dec 20052.56B-25.80%19.00M3.82B
FY200431 Dec 20043.45B+114.44%18.00M3.79B
FY200331 Dec 20031.61B-11.46%9.00M2.65B
FY200231 Dec 20021.82B+60.76%9.00M2.00B
FY200131 Dec 20011.13B-4.32%9.00M1.42B
FY200031 Dec 20001.18B+20.04%5.00M1.28B
FY199931 Dec 1999983.00M+125.46%6.00M993.00M
FY199831 Dec 1998436.00M+2,625.00%34.00M861.00M
FY199731 Dec 199716.00M—35.00M496.00M
FY199631 Dec 19960.00—34.09M397.04M
FY199531 Dec 19950.00—5.19M325.05M
FY199431 Dec 19940.00—4.63M246.65M
FY199331 Dec 19930.00—2.10M223.50M
FY199231 Dec 19920.00—1.00M166.60M
FY199131 Dec 19910.00-100.00%900.00K111.80M
FY199031 Dec 199022.50M—800.00K54.80M
FY198931 Dec 19890.00—0.0037.40M

Figures in USD. Free cash flow is operating cash flow less capital expenditure. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

The money spent buying back the company's own shares in each period, from the cash flow statement.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Cash flow

Common questions about Unitedhealth Group's buybacks

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.